Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_assertion type Assertion NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_head.
- NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_assertion description "[Study based on a small, well-characterized matched case-control group of patients with Parkinson disease (PD) suggests that the cholecystokinin system may influence the development of hallucinations in PD subjects.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_provenance.
- NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_assertion evidence source_evidence_literature NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_provenance.
- NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_assertion SIO_000772 15313848 NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_provenance.
- NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_assertion wasDerivedFrom lhgdn-20090331 NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_provenance.
- NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_assertion wasGeneratedBy ECO_0000203 NP206402.RAudEuxadMUq_avwPv7dVENo26riv4K-zb-VexCst_ILo130_provenance.